Celularity Inc. Class A Common Stock

CELUNASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
0.62 USD
↘ 0.05 (6.81%)AT CLOSE (11:59 AM EDT)
0.69
↗ 0.07 (11.29%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
0.69
↗ 0.07 (11.29%)
🔴Market: CLOSED

CELU is currently priced at $0.62. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (241.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CELU appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 26, 2026.

Open?$0.64
High?$0.68
Low?$0.57
Prev. Close?$0.67
Volume?222.1K
Avg. Volume?157.7K
VWAP?$0.61
Rel. Volume?1.41x
Bid / Ask
Bid?$0.58 × 1.6K
Ask?$0.72 × 4.4K
Spread?$0.14
Midpoint?$0.65
Valuation & Ratios
Market Cap?17.9M
Shares Out?28.9M
Float?7.3M
Float %?25.1%
P/E Ratio?N/A
P/B Ratio?-0.47
EPS?-$3.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Themes
Healthcare - Oncology›Cell & Gene Therapy for CancerBiotech - Drug Development›Clinical-Stage Platforms
Employees
115
Market Cap
19.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.celularity.com
Listed
2021-07-19
Address
170 PARK AVE
FLORHAM PARK, NJ 07932
Phone: (908) 768-2170
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
10
Short Sent.?
70
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.26Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.16%Elevated
Short Interest?375.0K
Days to Cover?2.2
Free Float7.3M
Avg Daily Volume170.0K
Settlement Date2026-06-15
Financial Health
Current Ratio?0.15Weak
Quick Ratio?0.15Weak
Cash Ratio?0.08Low
Debt/Equity?-1.26Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.47CHEAP▾
P/S?
Peers
100
S&P
92
0.68CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.1CHEAP▾
EV/Sales?
Peers
100
S&P
71
2.24CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
241.3%STRONG▾
ROA?
S&P
3
-85.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$59.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist